CHELSEY KAHLER: Open Payments
NPI 1053979708 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,379 in 84 payments from 14 companies in 2025. Trend: 2023 $1,216 · 2024 $1,365 · 2025 $1,379
Food & beverage: $1,379
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 18 | $320 |
| Bayer Healthcare Pharmaceuticals Inc. | 13 | $209 |
| ABBVIE INC. | 15 | $206 |
| Novo Nordisk Inc | 9 | $162 |
| Lilly USA, LLC | 10 | $154 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $67 |
| AstraZeneca Pharmaceuticals LP | 3 | $58 |
| Merck Sharp & Dohme LLC | 3 | $50 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
Products named: Kerendia, NURTEC ODT, ELIQUIS, Ozempic, QULIPTA, JARDIANCE, XIFAXAN, VRAYLAR.
Industry payments across AL — which companies pay providers there.
